Chitosan Nanoparticles of 5-Fluorouracil for Ophthalmic Delivery: Characterization, in-Vitro and in-Vivo Study

DOI Web Site Web Site 被引用文献1件 参考文献18件
  • Nagarwal Ramesh Chand
    Department of Pharmaceutics, Institute of Technology, Banaras Hindu University
  • Nath Singh Paras
    Department of Pharmaceutics, Institute of Technology, Banaras Hindu University
  • Kant Shri
    Department of Ophthalmology, Institute of Medical Sciences, Banaras Hindu University
  • Maiti Pralay
    School of Material Science & Technology, Institute of Technology, Banaras Hindu University
  • Pandit Jayanta Kumar
    Department of Pharmaceutics, Institute of Technology, Banaras Hindu University

この論文をさがす

抄録

The aim of this investigation was to develop 5-fluorouracil (5-FU) loaded chitosan nanoparticles (CH-DNPs) for ophthalmic delivery. CH-DNPs were fabricated by ionotropic gelation mechanism using chitosan (CH) and a polyanion (TPP). The nanoparticles were smooth and spherical, confirmed by scanning electron microscopy (SEM) and atomic force microscope (AFM). CH/TPP mass ratio and TPP significantly changed the particles size morphology and encapsulation efficiency. The nanoparticles size ranged from approximately 114 to 192 nm and had a positive zeta potential (30±4 mV). The encapsulation efficiency, loading capacity and recovery of DNPs were 8.12—34.32%, 3.14—15.24% and 24.22 to 67% respectively. Physical characterization was done by Fourier transform infrared (FT-IR) and X-ray diffraction (XRD). No interaction was observed in between drug and polymer and crystallinity of drug was not changed in drug loaded nanoparticles. In-vitro release study of DNPs showed diffusion controlled release. Bioavailability study of batch CS9 was studied in rabbit eye and compare to 5-FU solution. 5-FU level was significantly higher in aqueous humor of rabbit eye. Ocular tolerance was studied in the eye of New Zealand rabbits and tested formulation was non-irritant with no sign of inflammation.

収録刊行物

被引用文献 (1)*注記

もっと見る

参考文献 (18)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ